• Key Facts

    Latest information about our company.


    Global Business

    Updated January 2017

    Chief Executive Officer:
    Headquarters:
    New York City
    Business:
    Biopharmaceuticals
    Web Address:
    NYSE Listing:
    BMY
    Net Global Sales:
    $19.4 billion in 2016
    R&D Investment:
    $4.94 billion which included the discovery and development of new medicines for patients
    Principal Locations:

    Local Business

    Updated July 2017

    Australian head office:
    Level 2, 4 Nexus Court, Mulgrave,?Victoria 3170, Australia
    Key Products in Market:
    BARACLUDE? (entecavir)
    DAKLINZA? (daclatasvir)
    ELIQUIS? (apixaban)
    EVOTAZ? (atazanavir & cobicistat)
    OPDIVO? (nivolumab)
    ORENCIA? (abatacept)
    REYATAZ? (atazanavir sulfate)
    SPRYCEL? (dasatinib)
    SUNVEPRA? (asunaprevir)
    YERVOY? (ipilimumab)

    能看AV永久免费的APP